Syncona
Limited
Issue of shares
pursuant to the Long Term Incentive Plan
13 August 2018
Syncona Limited (the "Company") today announces that a total of
20,836 new ordinary shares will be issued in satisfaction of
realisations under the Company’s Long Term Incentive Plan.
The new ordinary shares, when issued, will rank pari passu with the
existing issued ordinary shares of the Company.
In accordance with the rules of the Long Term Incentive Plan,
ordinary shares delivered on realisation may not be sold or
transferred by the recipient for a period of one year following the
realisation date.
Application has been made to the Financial Conduct Authority for
the shares to be admitted to the Official List, and to the London
Stock Exchange for the shares to be admitted to trading and it is
expected that dealings will commence in the new ordinary shares on
16 August 2018.
[ENDS]
Enquiries
Syncona Ltd
Annabel Clay
Tel: +44 (0) 20 7611 2031
Northern Trust International Fund Administration Services
(Guernsey) Limited
Company Secretary
Tel: 01481 745001
Copies of this press release and other corporate information
can be found on the company website at: www.synconaltd.com
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on
investing in and building global leaders in life science. Our
vision is to deliver transformational treatments to patients in
truly innovative areas of healthcare while generating superior
returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital,
and are established leaders in gene and cell therapy. We focus on
delivering dramatic efficacy for patients in areas of high unmet
need.